Mike Stratton

Director/Board Member at Wellcome Trust Sanger Institute

Health Technology

Profile

Mike Stratton is the founder of Quotient Therapeutics Ltd., which was founded in 2022.
He is currently the Director at Wellcome Trust Sanger Institute.

Mike Stratton active positions

Companies	Position	Start
Wellcome Trust Sanger Institute Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom.	Director/Board Member	-

All active positions of Mike Stratton

Former positions of Mike Stratton

Companies	Position	End

See the detail of Mike Stratton's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mike Stratton's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Wellcome Trust Sanger Institute Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom.	Health Technology